Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension

被引：0
|
作者：
Mona Abd Elsalam Taha El Gazzar [1 ]
Wafaa Saleh El Shimy [1 ]
Hanan Mohamed Elsaadany [2 ]
Mohamed Sayed Hantera [1 ]
Basem Ibrahim Elshafey [1 ]
机构：
[1] Tanta University,Chest Diseases Department, Faculty of Medicine
[2] Tanta University, Rheumatology, Rehabilitation and physical medicine Department, Faculty of Medicine
来源：
The Egyptian Journal of Bronchology | / 19卷 / 1期
关键词：
Interstitial lung disease; Pulmonary rehabilitation; Pulmonary hypertension;
D O I：
10.1186/s43168-025-00405-2
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pulmonary Rehabilitation and Interstitial Lung Disease AIDING THE REFERRAL DECISION
    Johnson-Warrington, Vicki
    Williams, Johanna
    Bankart, John
    Steiner, Michael
    Morgan, Mike
    Singh, Sally
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2013, 33 (03) : 189 - 195
  • [22] Interstitial lung diseases and pulmonary hypertension
    Hauber, H. P.
    INTERNIST, 2009, 50 (09): : 1072 - +
  • [23] Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
    Haynes, Zachary A.
    Chandel, Abhimanyu
    King, Christopher S.
    CELLS, 2023, 12 (19)
  • [24] Pulmonary Rehabilitation in patients with Interstitial Lung Disease: The effects of a 12-week programme
    Sciriha, Anabel
    Lungaro-Mifsud, Stephen
    Fsadni, Peter
    Scerri, Josianne
    Montefort, Stephen
    RESPIRATORY MEDICINE, 2019, 146 : 49 - 56
  • [25] Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease
    Lawrence, Alexandra
    Myall, Katherine Jane
    Mukherjee, Bhashkar
    Marino, Philip
    LIFE-BASEL, 2024, 14 (09):
  • [26] Management of pulmonary hypertension resulting from interstitial lung disease
    Shapiro, S
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (05) : 426 - 430
  • [27] Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
    Jessica L. Fairley
    Dylan Hansen
    Laura Ross
    Susanna Proudman
    Joanne Sahhar
    Gene-Siew Ngian
    Jennifer Walker
    Lauren V. Host
    Kathleen Morrisroe
    Diane Apostolopoulous
    Nava Ferdowsi
    Michelle Wilson
    Maryam Tabesh
    Wendy Stevens
    Mandana Nikpour
    Arthritis Research & Therapy, 25
  • [28] Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease
    Launay, David
    Mouthon, Luc
    Hachulla, Eric
    Pagnoux, Christian
    de Groote, Pascal
    Remy-Jardin, Martine
    Matran, Regis
    Lambert, Marc
    Queyrel, Viviane
    Morell-Dubois, Sandrine
    Guillevin, Loic
    Hatron, Pierre-Yves
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (05) : 1005 - 1011
  • [29] Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
    Hoeper, Marius M.
    Halank, Michael
    Wilkens, Heinrike
    Guenther, Andreas
    Weimann, Gerrit
    Gebert, Irmingard
    Leuchte, Hanno H.
    Behr, Juergen
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) : 853 - 860
  • [30] Interstitial lung diseases and pulmonary hypertension
    Hauber, H. P.
    INTERNIST, 2009, 50 (09): : 1072 - +
12345